Physicians at The Arthritis Research Centre of Canada are seeking volunteers who have been diagnosed with active Ankylosing Spondylitis (AS) to participate in a clinical research study involving an investigational study drug not yet approved by Health Canada.

Volunteers with AS who in the past have not responded to standard anti-inflammatory medications and/or 1 anti TNFa who meet criteria for entry into the study, and who consent to participation, would be randomly assigned to receive either active potential treatment (by a series of 3 intravenous infusions followed by sub-cutaneous injections given every 4 weeks) or placebo (an inactive substance by a series of 3 intravenous infusions followed by subcutaneous injections given every 4 weeks). The chance of receiving placebo is 1 in 3 for a maximum of 24 weeks. Participation in the study would involve 31 visits to the Arthritis Research Centre over 2 years.

If you are interested in learning more about this study and what participation would involve, please contact the Study Coordinators:

The principal investigator for this study is Dr. Andrew Chalmers. 

Please discuss your participation in this or any research study with your primary physician.

Clinical Trials Group
Arthritis Research Centre of Canada
2nd floor, Room 210
895 West 10th Ave.
Vancouver, BC